Saw palmetto is not a blood thinner in the traditional sense. It does not work like anticoagulant medications, and controlled clinical trials have found no measurable increase in bleeding risk. That said, there is a theoretical mechanism by which it could affect platelet function, and a small number of case reports have raised concerns worth understanding, especially if you’re preparing for surgery.
How Saw Palmetto Might Affect Clotting
Saw palmetto has anti-inflammatory properties that work partly by blocking an enzyme called cyclooxygenase, the same enzyme targeted by aspirin and ibuprofen. Because this enzyme plays a role in how platelets clump together to form clots, researchers have theorized that saw palmetto could interfere with normal clotting through this pathway. This is where the “blood thinner” concern originates.
However, the theoretical concern and the clinical reality don’t match up well. No studies have found that saw palmetto raises prothrombin time, partial thromboplastin time, or INR, which are the standard lab markers doctors use to assess clotting ability. One small study in 10 volunteers found that saw palmetto ingestion did not affect platelet function tests at all. The mechanism exists on paper, but it hasn’t shown up reliably in actual blood work.
What Clinical Trials Actually Show
The strongest evidence comes from two randomized controlled trials that specifically looked at bleeding during prostate surgery in men taking saw palmetto. Neither trial found increased bleeding. A 2022 review published in the Proceedings of Baylor University Medical Center categorized saw palmetto in the “no risk” group for bleeding, alongside fish oil and ginseng. That classification was based on the highest tiers of clinical evidence: systematic reviews, randomized controlled trials, and large case series.
A detailed safety assessment from the STEP trial, which followed 112 people taking saw palmetto and 113 on placebo, found no significant differences in bleeding-related side effects. Blood in the urine was actually less common in the saw palmetto group (2.9%) than in the placebo group (6.5%), though the difference wasn’t statistically significant. One case of gastrointestinal bleeding occurred in the saw palmetto group during the trial, but isolated events in a trial this size don’t establish a pattern.
The Case Reports That Raised Concern
A handful of individual case reports have described bleeding events in people taking saw palmetto. The most cited is a 53-year-old man who experienced excessive bleeding during brain tumor surgery while taking the supplement. But the NIH notes that the specific product, preparation, and dosage were never reported, and the symptoms could be consistent with a contaminated product (potentially one that contained traces of warfarin, an actual blood thinner).
Another case report described a 61-year-old man whose INR rose modestly from 2.4 to 3.4 after taking a saw palmetto product alongside warfarin for six days. That increase is noteworthy but modest, and the product he used (Curbicin) contained ingredients beyond just saw palmetto. Case reports like these document what happened to one person. They don’t establish that saw palmetto caused the problem, and the broader clinical trial data hasn’t confirmed the pattern.
Interactions With Blood-Thinning Medications
If you take warfarin or a similar anticoagulant, the interaction risk with saw palmetto is considered doubtful based on current evidence. Lab research has found that saw palmetto may inhibit CYP2C9, a liver enzyme involved in processing warfarin. In theory, this could make warfarin stay in your system longer and increase its blood-thinning effect. In practice, the evidence is limited to the single case report mentioned above and one experimental study of unknown clinical relevance.
A comprehensive review of herb-warfarin interactions rated the saw palmetto interaction as minor, with a low level of evidence. Still, if you’re on anticoagulants, it’s worth mentioning your saw palmetto use to whoever manages your medication, since even a small shift in INR can matter for people whose clotting needs careful management.
Surgery Precautions
Despite the reassuring trial data, many healthcare systems still recommend stopping saw palmetto before surgery as a precaution. Kaiser Permanente, for example, advises discontinuing it at least two weeks before any surgical procedure. This isn’t unique to saw palmetto. It’s standard practice for many supplements that have even a theoretical effect on clotting, since the consequences of unexpected surgical bleeding are serious enough to justify caution even when the risk is low.
The typical dose used in clinical studies is 320 mg daily, usually split into 160 mg twice a day. If you’re taking significantly more than this, the safety data from trials may not fully apply to your situation, since most research has been conducted at or near this standard dose.
The Bottom Line on Bleeding Risk
Saw palmetto is not a blood thinner. It does not thin your blood the way aspirin, warfarin, or other anticoagulants do. The best available clinical evidence, including two randomized trials focused specifically on surgical bleeding, has found no increased risk. The handful of concerning case reports involve confounding factors like contaminated products and combination supplements. For most people taking a standard dose, bleeding is not a realistic concern, though the two-week pre-surgery pause remains a sensible precaution.